{"podcast":{"title":"Weekly Dose of GenAI Adoption","slug":"weekly-dose-of-genai-adoption-7090547","podcast_index_feed_id":7090547,"rss_url":"https://anchor.fm/s/fbda5fd8/podcast/rss","website_url":"https://www.linkedin.com/in/indysawhney/","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/42153926/42153926-1728036654385-e3e8e0797afcc.jpg","author":"Indy Sawhney","episode_count":113,"summary":"Welcome to the \"Accelerating GenAI Adoption Podcast\" hosted by Indy Sawhney. Weekly AI-hosted discussions explore GenAI insights, use cases, and research based on Indy's LinkedIn newsletters. Experience newsletter content as dynamic audio conversations to enhance your understanding of generative AI technologies. Tune in for thought-provoking dialogues that empower you to navigate the evolving GenAI landscape. Music credits: I Miss You, Southern Winds by | e s c p | https://www.escp.space https://escp-music.bandcamp.com","last_synced_at":"2026-06-07T10:22:36.634878+00:00","page_url":"https://stenobird.com/podcast/weekly-dose-of-genai-adoption-7090547"},"episode":{"title":"Weekly Dose of AI Adoption","slug":"weekly-dose-of-ai-adoption","published_at":"2026-05-09T12:49:01+00:00","page_url":"https://stenobird.com/podcast/weekly-dose-of-genai-adoption-7090547/weekly-dose-of-ai-adoption","show_page_url":"https://stenobird.com/podcast/weekly-dose-of-genai-adoption-7090547","url":"https://podcasters.spotify.com/pod/show/indy-sawhney/episodes/Weekly-Dose-of-AI-Adoption-e3j4enk","audio_url":"https://anchor.fm/s/fbda5fd8/podcast/play/119732404/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-9%2F423808795-44100-2-2b5559e9698dd.m4a","summary":"This newsletter from Indy Sawhney provides a strategic framework for calculating the Return on Investment (ROI) of agentic AI within the pharmaceutical industry. It emphasizes that traditional financial models often fail because they ignore the high program costs of regulated deployments and rely too heavily on minor labor savings. Instead, the text argues that the primary financial value of AI stems from timeline compression, which allows drugs to reach the market faster. To secure funding, leaders are encouraged to collaborate with CFOs and technical stakeholders to validate these assumptions with real production data. Ultimately, the source serves as a practical playbook for navigating the complex financial and regulatory realities of large-scale AI adoption.","meta_description":"This newsletter from Indy Sawhney provides a strategic framework for calculating the Return on Investment (ROI) of agentic AI within the pharmaceutical in…","key_points":[],"chapters":[],"topics":[],"duration_seconds":378,"processing_state":"processed","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/weekly-dose-of-genai-adoption-7090547/episodes/weekly-dose-of-ai-adoption/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/weekly-dose-of-genai-adoption-7090547/weekly-dose-of-ai-adoption.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}